IAA
Ironsides Asset Advisors’s Kezar Life Sciences KZR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,920
| Closed | -$34.2K | – | 97 |
|
|
2023
Q1 | $34.2K | Hold |
10,920
| – | – | 0.02% | 90 |
|
|
2022
Q4 | $77K | Hold |
10,920
| – | – | 0.04% | 85 |
|
|
2022
Q3 | $94K | Buy |
10,920
+300
| +3% | +$2.58K | 0.04% | 81 |
|
|
2022
Q2 | $88K | Sell |
10,620
-400
| -4% | -$3.32K | 0.03% | 95 |
|
|
2022
Q1 | $183K | Hold |
11,020
| – | – | 0.06% | 93 |
|
|
2021
Q4 | $184K | Sell |
11,020
-50
| -0.5% | -$835 | 0.05% | 90 |
|
|
2021
Q3 | $96K | Sell |
11,070
-5,740
| -34% | -$49.8K | 0.03% | 94 |
|
|
2021
Q2 | $91K | Sell |
16,810
-3,820
| -19% | -$20.7K | 0.03% | 99 |
|
|
2021
Q1 | $123K | Buy |
20,630
+300
| +1% | +$1.79K | 0.04% | 91 |
|
|
2020
Q4 | $106K | Buy |
20,330
+1,525
| +8% | +$7.95K | 0.03% | 80 |
|
|
2020
Q3 | $91K | Buy |
18,805
+2,805
| +18% | +$13.6K | 0.03% | 72 |
|
|
2020
Q2 | $83K | Hold |
16,000
| – | – | 0.03% | 77 |
|
|
2020
Q1 | $70K | Buy |
+16,000
| New | +$70K | 0.04% | 68 |
|
|
2019
Q4 | – | Sell |
-17,650
| Closed | -$58K | – | 94 |
|
|
2019
Q3 | $58K | Hold |
17,650
| – | – | 0.02% | 95 |
|
|
2019
Q2 | $136K | Buy |
17,650
+5,886
| +50% | +$45.4K | 0.05% | 93 |
|
|
2019
Q1 | $209K | Buy |
+11,764
| New | +$209K | 0.07% | 92 |
|